Delivery Order SPE2DB20D1100-SPE2DB25FA3Y5
Award Date
1/31/25
Potential Completion Date
2/3/25
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,374.22 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a medication, to support federal healthcare programs. The contract has an ultimate completion date of February 20, 2025 and was awarded on February 19, 2025. This award is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award, with ID SPE2DB20D1051|SPE2DB25FD7AZ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,572.63 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a performance period ending on February 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award with ID SPE2DB25D3006|SPE2DB25FXHEL was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,122.94 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a medication, with a completion date of February 20, 2025. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,559.03, is a Firm Fixed Price Delivery Order for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,255.61 firm fixed-price delivery order is for the supply of VRAYLAR 6 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $16,825.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, to support military...
This federal contract award, identified as SPE2DB22D1103|SPE2DB25FTDP6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,520.10, is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 2, 2025. The contract covers the procurement of VRAYLAR 1.5 MG CAPSULE 30S, a medical product, to support federal healthcare programs....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $5,277.58 with a firm fixed price for the delivery of VRAYLAR 4.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of January 15, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $23,827.02 for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of January 23, 2025. The award is not associated with a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VRAYLAR 3 MG CAPSULE 30S. The $5,236.84 firm fixed-price delivery order has a completion date of January 19, 2023 and was awarded on January 18, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...